Company

COMPANY

COMPANY

A PRECISE, PRACTICAL APPROACH TO
4D BIO-FABRICATED TRANSPLANTABLE
TISSUES AND ORGANS

Precise Bio is a regenerative medicine company that is advancing the use of bio-printed tissues and organs in patients in ophthalmology and is building a broad portfolio of R&D programs in additional medical disciplines.

The company’s commercial and R&D programs are based on its innovative 4D-bio-fabrication technology. This innovative platform comprises cell expansion, biomaterials, processes, printing technology and other critical technologies that are leading the way toward generating a robust pipeline of proprietary products with substantial clinical and commercial value.

The company’s robust technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company’s technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs. This positions Precise Bio for leadership in the field of regenerative medicine to address unmet needs in many indications which cannot be treated with donor tissue, or are limited by the number of available donor tissues and organs.

The company maintains offices, laboratories and production facilities in North Carolina, in the U.S. and in Shoham, Israel.

MANAGEMENT

Our team and advisory boards are made up of pioneers in the fields of tissue engineering, bio-materials, regenerative medicine and 3D printing. Read more

PARTNERSHIPS

We are joining forces with biotech and tissue engineering companies who share our mission of making transplantable organs and tissues readily available and commercially viable. Read more

MANAGEMENT

ARYEH BATT
ARYEH BATTCo-Founder & CEO
Aryeh has over two decades of executive experience leading product management and development of innovative technology products, and bringing them from R&D to marketing and sales. He served as Vice President of Business and Director of Corporate R&D at Orbotech (NASDAQ: ORBK) and CTO, Vice President of Business Development and Vice President of R&D at MangoDSP, a leading developer in signal processing. He holds a BSc in Physics and Electro-optics Engineering from the Jerusalem College of Technology.
ANTHONY ATALA,
ANTHONY ATALA,Co-Founder & CMO
Tony is the W.H. Boyce Professor and Director of the Wake Forest Institute for Regenerative Medicine. He is recognized as a worldwide leader in regenerative medicine and its translation into clinical practice. He is a member of the Institute of Medicine of the National Academy of Sciences, and serves as President of the Regenerative Medicine Foundation.
SHAY SOKER,
SHAY SOKER,Co-Founder & CSO
Shay is Professor of Regenerative Medicine and Biomedical Engineering at the Wake Forest School of Medicine in the U.S. He is a world-renown expert in molecular and cellular biology, and natural biomaterials, with extensive experience in tissue and organ engineering. Many of Shay’s research projects have progressed to clinical practice and others are currently being discussed with Industry leaders.
AMOS EITAN
AMOS EITANVP R&D
Amos brings over 15 years of experience in optical engineering. Prior to joining Precise Bio, he managed R&D multidisciplinary teams in various fields, ranging from optical communications to solar energy and biotech. He holds a BSc in Physics and Electro-optics Engineering from the Jerusalem College of Technology.
YISHAY HAYARDENI
YISHAY HAYARDENIVP Projects and System
Yishay has over 25 years of experience in technology development and management, managing development teams in a wide range of multidisciplinary projects, including electronics, optical mechanics, software and machine vision. He holds a BSc in Electrical Engineering from the Jerusalem College of Technology.
EYAL ARIELI
EYAL ARIELICFO/COO
Eyal has over 25 years of experience in executive management, financial, commercial and operational experience in the pharma industry working in multi -cultural environments. Vast experience in managing and growing local and global organizations, integrating newly acquired companies and creating and managing alliances. Eyal held various positions in Teva, amongst them CEO of Teva SA, CEO of Teva India and Director of finance. Eyal holds an MBA from Bar-Ilan University and BA in Economics from Jerusalem University.
MEITAL PEER
MEITAL PEERVP HR
Meital has nearly 20 years of experience in Human Resource management in HR roles. Meital brings a track record of HR Business Partner roles in the global technology environment based in Israel.
Meital has vast experience in organizational and personal development consultant. In her previous roles Meital was Head of HR in Hexagon and HR Business partner at Orbotech (NASDAQ: ORBK).
Meital holds a BA and MBA in Behavioral Science from the College of Management.

MEDICAL ADVISORY BOARD

RICHARD L. LINDSTROM,
RICHARD L. LINDSTROM,
Dr. Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants and an internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He currently serves as an Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology, and visiting professor at the UC Irvine Gavin Herbert Eye Institute. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.

Dr. Lindstrom has been awarded over 40 patents in ophthalmology and has developed a number of corneal preservation solutions, intraocular lenses and instruments that are used in clinical practices globally. He serves on many Board of Directors and is a frequent lecturer throughout the world on cornea, cataract, glaucoma, laser and refractive surgery. After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972.

Dr. Lindstrom has previously served as president of the International Society of Refractive Surgery from 1993 to 1994, the International Intraocular Implant Society from 2002 to 2004, the International Refractive Surgery Club from 2002 to 2004, and the American Society of Cataract and Refractive Surgery (“ASCRS”) from 2007 to 2008.